BEAM vs RUN · rev $63.5M vs P/E 6.0, rev $2.04B
Beam Therapeutics Inc (BEAM) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
BEAM currently screens at market cap $2.01B. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the BEAM and RUN stock pages for the full models.
Not investment advice.